We are pleased to announce the results of the 2021 IASLC Board of Directors (BOD) election. We received a strong slate of candidates for a limited number of open Board of Directors positions, and the IASLC thanks you for taking part in this process.
From submitting nominations and campaigning to sharing your thoughts and opinions, your engagement, enthusiasm, and passion are central to why the IASLC remains the premier global lung cancer research organization.
Please join us in thanking our Nominating Committee for their service, and in welcoming our returning board members: Drs. Heather Wakelee, Tetsuya Mitsudomi, Andrea Bezjak, Roy Herbst, Erik Thunnissen, and Caicun Zhou.
Our sincere thanks to those board members who will rotate off in September 2021: Drs. Giorgio Scagliotti, Enriqueta Felip, Suresh Ramalingam, Julie Brahmer, Anne Fraser, Clarissa Mathias, Yuko Nakayama, Masayuki Noguchi, Nir Peled, and James Yang.
Of 3,855 eligible voters, 1,167 ballots were cast over the course of the election, a participation percentage of 30.2%. Votes were cast in 48 countries, with the largest turnout being from the United States, followed by Japan.
The newly elected IASLC board members will officially assume their roles at the upcoming IASLC 2021 World Conference on Lung Cancer Denver | Worldwide Virtual Event (WCLC 2021) on September 8-14, 2021. These new board members will serve a four-year term (2021-2025) and will help shape the direction and strategy of the IASLC.
We look forward to working alongside this incredible group of medical professionals as together we continue to provide you with the world-class experience you have come to expect as members of the IASLC.
As an IASLC Board member, how do you envision helping the organization adhere to its international and multidisciplinary mission?
See the newly elected board members' full answers below by clicking on the red + on the bottom of their block.